Recombinant RSV G protein vaccine induces enhanced respiratory disease via IL-13 and mucin overproduction

Eigo Kawahara, Kota Senpuku, Yoshino Kawaguchi, Shinya Yamamoto, Koubun Yasuda, Etsushi Kuroda, Noriko Ouji-Sageshima, Toshihiro Ito, Toshiro Hirai, Takehiko Shibata, Yasuo Yoshioka*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Fingerprint

Dive into the research topics of 'Recombinant RSV G protein vaccine induces enhanced respiratory disease via IL-13 and mucin overproduction'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Keyphrases

Immunology and Microbiology